PTO Form 1478 (Rev 9/2006) |
OMB No. 0651-0009 (Exp 12/31/2011) |
Trademark/Service Mark Application, Principal Register
Serial Number: 85476614 |
Filing Date: 11/18/2011 |
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
85476614 |
MARK INFORMATION |
*MARK |
TALTZ |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
TALTZ |
MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font, style, size, or color. |
REGISTER |
Principal |
APPLICANT INFORMATION |
*OWNER OF MARK |
Eli Lilly and Company |
*STREET |
Lilly Corporate Center |
*CITY |
Indianapolis |
*STATE
(Required for U.S. applicants) |
Indiana |
*COUNTRY |
United States |
*ZIP/POSTAL CODE
(Required for U.S. applicants only) |
46285 |
PHONE |
317-276-9624 |
FAX |
317-276-1919 |
EMAIL ADDRESS |
XXXX |
WEBSITE ADDRESS |
www.lilly.com |
LEGAL ENTITY INFORMATION |
TYPE |
corporation |
STATE/COUNTRY OF INCORPORATION |
Indiana |
GOODS AND/OR SERVICES AND BASIS INFORMATION |
INTERNATIONAL CLASS |
005 |
*IDENTIFICATION |
Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's,
anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and
disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders,
hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle
diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and
disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; veterinary preparations |
FILING BASIS |
SECTION 1(b) |
ADDITIONAL STATEMENTS SECTION |
MISCELLANEOUS STATEMENT |
The mark is a coined, non-dictionary word with no English translation. |
ATTORNEY INFORMATION |
NAME |
Robert E. Lee, Jr. |
FIRM NAME |
Eli Lilly and Company |
STREET |
Lilly Corporate Center |
CITY |
Indianapolis |
STATE |
Indiana |
COUNTRY |
United States |
ZIP/POSTAL CODE |
46285 |
PHONE |
317-276-9624 |
FAX |
317-276-1919 |
EMAIL ADDRESS |
trademarks@lilly.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
OTHER APPOINTED ATTORNEY |
Bruce W. Longbottom, Lawrence T. Welch, and Douglas K. Norman |
CORRESPONDENCE INFORMATION |
NAME |
Robert E. Lee, Jr. |
FIRM NAME |
Eli Lilly and Company |
STREET |
Lilly Corporate Center |
CITY |
Indianapolis |
STATE |
Indiana |
COUNTRY |
United States |
ZIP/POSTAL CODE |
46285 |
PHONE |
317-276-9624 |
FAX |
317-276-1919 |
EMAIL ADDRESS |
trademarks@lilly.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
FEE INFORMATION |
NUMBER OF CLASSES |
1 |
FEE PER CLASS |
325 |
*TOTAL FEE DUE |
325 |
*TOTAL FEE PAID |
325 |
SIGNATURE INFORMATION |
SIGNATURE |
/reljr44/ |
SIGNATORY'S NAME |
Robert E. Lee, Jr. |
SIGNATORY'S POSITION |
Assistant General Patent Counsel |
DATE SIGNED |
11/18/2011 |
PTO Form 1478 (Rev 9/2006) |
OMB No. 0651-0009 (Exp 12/31/2011) |
Trademark/Service Mark Application, Principal Register
Serial Number: 85476614 |
Filing Date: 11/18/2011 |
To the Commissioner for Trademarks:
MARK: TALTZ (Standard Characters, see
mark)
The literal element of the mark consists of TALTZ.
The mark consists of standard characters, without claim to any particular font, style, size, or color.
The applicant, Eli Lilly and Company, a corporation of Indiana, having an address of
Lilly Corporate Center
Indianapolis, Indiana 46285
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders,
Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system
diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases
and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders,
migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive
system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; veterinary preparations
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or
services. (15 U.S.C. Section 1051(b)).
The mark is a coined, non-dictionary word with no English translation.
For informational purposes only, applicant's website address is: www.lilly.com
The applicant's current Attorney Information:
Robert E. Lee, Jr. and Bruce W. Longbottom, Lawrence T. Welch, and Douglas K. Norman of Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285
United States
The applicant's current Correspondence Information: |
Robert E. Lee, Jr. |
Eli Lilly and Company |
Lilly Corporate Center |
Indianapolis, Indiana 46285 |
317-276-9624(phone) |
317-276-1919(fax) |
trademarks@lilly.com (authorized) |
A fee payment in the amount of $325 has been submitted with the application, representing payment for 1 class(es).
Declaration
The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the
applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes
applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either
in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake,
or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.
Signature: /reljr44/ Date Signed: 11/18/2011
Signatory's Name: Robert E. Lee, Jr.
Signatory's Position: Assistant General Patent Counsel
RAM Sale Number: 1867
RAM Accounting Date: 11/21/2011
Serial Number: 85476614
Internet Transmission Date: Fri Nov 18 15:19:25 EST 2011
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XX-20111118151925422
361-85476614-4806481fdd7e1d644c3201e862f
852ec3d5-DA-1867-20111118141258702589